Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- 123 Actinomycosis
- 124 Anaerobic infections
- 125 Anthrax and other Bacillus species
- 126 Bartonella bacilliformis
- 127 Cat scratch disease and other Bartonella infections
- 128 Bordetella
- 129 Branhamella–Moraxella
- 130 Brucellosis
- 131 Campylobacter
- 132 Clostridium
- 133 Corynebacteria
- 134 Enterobacteriaceae
- 135 Enterococcus
- 136 Erysipelothrix
- 137 HACEK
- 138 Helicobacter pylori
- 139 Gonococcus: Neisseria gonorrhoeae
- 140 Haemophilus
- 141 Legionellosis
- 142 Leprosy
- 143 Meningococcus and miscellaneous neisseriae
- 144 Listeria
- 145 Nocardia
- 146 Pasteurella multocida
- 147 Pneumococcus
- 148 Pseudomonas, Stenotrophomonas, and Burkholderia
- 149 Rat-bite fevers
- 150 Salmonella
- 151 Staphylococcus
- 152 Streptococcus groups A, B, C, D, and G
- 153 Viridans streptococci
- 154 Poststreptococcal immunologic complications
- 155 Shigella
- 156 Tularemia
- 157 Tuberculosis
- 158 Nontuberculous mycobacteria
- 159 Vibrios
- 160 Yersinia
- 161 Miscellaneous gram-positive organisms
- 162 Miscellaneous gram-negative organisms
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
141 - Legionellosis
from Part XVIII - Specific organisms: bacteria
Published online by Cambridge University Press: 05 April 2015
Edited by
Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- 123 Actinomycosis
- 124 Anaerobic infections
- 125 Anthrax and other Bacillus species
- 126 Bartonella bacilliformis
- 127 Cat scratch disease and other Bartonella infections
- 128 Bordetella
- 129 Branhamella–Moraxella
- 130 Brucellosis
- 131 Campylobacter
- 132 Clostridium
- 133 Corynebacteria
- 134 Enterobacteriaceae
- 135 Enterococcus
- 136 Erysipelothrix
- 137 HACEK
- 138 Helicobacter pylori
- 139 Gonococcus: Neisseria gonorrhoeae
- 140 Haemophilus
- 141 Legionellosis
- 142 Leprosy
- 143 Meningococcus and miscellaneous neisseriae
- 144 Listeria
- 145 Nocardia
- 146 Pasteurella multocida
- 147 Pneumococcus
- 148 Pseudomonas, Stenotrophomonas, and Burkholderia
- 149 Rat-bite fevers
- 150 Salmonella
- 151 Staphylococcus
- 152 Streptococcus groups A, B, C, D, and G
- 153 Viridans streptococci
- 154 Poststreptococcal immunologic complications
- 155 Shigella
- 156 Tularemia
- 157 Tuberculosis
- 158 Nontuberculous mycobacteria
- 159 Vibrios
- 160 Yersinia
- 161 Miscellaneous gram-positive organisms
- 162 Miscellaneous gram-negative organisms
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 924 - 930Publisher: Cambridge University PressPrint publication year: 2015
References
, , . Risk for travel-associated Legionnaires’ Disease, Europe, 2009. Emerg Infect Dis. 2012;18:1811–1816.CrossRefGoogle ScholarPubMed
, , , et al. Factors associated with mortality in community-acquired legionellosis in France. Eur Respir J. 2012;39:963–970.CrossRefGoogle Scholar
, , , et al. Sporadic legionellosis in the US: the first 1000 cases. Ann Intern Med. 1981;94:164–170.CrossRefGoogle Scholar
, , , et al. Legionnaires’ disease – description of an epidemic of pneumonia. N Engl J Med. 1977;297:1189–1197.CrossRefGoogle ScholarPubMed
, , , et al. Clinical outcomes for hospitalized patients with Legionella pneumonia in the antigenuria era: the influence of levofloxacin therapy. Clin Infect Dis. 2005;40:794–799.CrossRefGoogle ScholarPubMed
, . Legionella: macrolide or quinolones?Clin Microbiol Infect Dis. 2006;12(Suppl 3):30–35.CrossRefGoogle ScholarPubMed
, , , et al.; ; . Guidelines for preventing health-care-associated pneumonia. MMWR Recomm Rep. 2004;53(RR-3):1–36.Google ScholarPubMed
, , , et al. Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: an international collaborative survey. J Infect Dis. 2002;186:127–128.CrossRefGoogle ScholarPubMed